| 3-(3-hydroxy-1-oxo-2-phenylpropoxy)- 8-methyl-8-(1-methylethyl)-, (endo,syn)-(+-)-8-azoniabicyclo(3.2.1)octane | |
| CAS number 60205-81-4, 22254-24-6 (bromide) and 66985-17-9 (bromide) | ATC code R01AX03 and R03BB01 |
| Chemical formula | C20H30NO3 |
| Molecular weight | 350.5 or 430.4 (with bromide) |
| Bioavailability | ? |
| Metabolism | ? |
| Elimination half-life | ? |
| Excretion | ? |
| Pregnancy category | ? |
| Legal status | ? |
| Routes of administration | ? |
It is available under the trade names Alti-Ipratropium (AltiMed), Apo-Ipravent (Apotex), Atrovent Inhalation Aerosol (Boehringer Ingelheim), Atrovent Inhalation Solution (Boehringer Ingelheim), Atrovent Nasal Spray (Boehringer Ingelheim), Gen-Ipratropium (Genpharm), Novo-Ipramide (Novopharm), Nu-Ipratropium (Nu-Pharm), PMS-Ipratropuim (Pharmascience).
More on [ Ipratropium ]

Combivent - Information on living better with COPD (chronic obstructive pulmonary disease). Details about Atrovent MDI and the Combivent IA Inhaler.
DrugDigest: Ipratropium Inhalation ( Atrovent nasal ) - Information on dosage, usage, side effects, interactions, and drug comparisons, including generics when available.